| LCBEX | VIVIX | LCBEX / VIVIX | |
| Total Expense Ratio | 0.66 | 0.04 | 1,650% |
| Annual Report Gross Expense Ratio | 0.66 | 0.04 | 1,650% |
| Fund Existence | 13 years | 28 years | - |
| Gain YTD | 0.935 | 14.037 | 7% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 5000000 | 20% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 8.98B | 216B | 4% |
| Annual Yield % from dividends | 1.34 | 2.05 | 65% |
| Returns for 1 year | -0.42 | 12.67 | -3% |
| Returns for 3 years | 16.17 | 37.82 | 43% |
| Returns for 5 years | 21.50 | 65.02 | 33% |
| Returns for 10 years | 75.98 | 134.87 | 56% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| IMIDX | 19.54 | 0.03 | +0.15% |
| Congress Mid Cap Growth Institutional | |||
| JACEX | 18.13 | 0.01 | +0.06% |
| JHancock Mid Cap Growth R6 | |||
| PAXGX | 16.74 | N/A | N/A |
| Impax Global Opportunities Investor | |||
| MISAX | 19.84 | -0.01 | -0.05% |
| Victory Trivalent International Sm-Cp A | |||
| RERFX | 60.42 | -0.04 | -0.07% |
| American Funds EUPAC R5 | |||